Centers for Disease Control and Prevention. Venous thromboembolism in adult hospitalizations—United States, 2007–2009. MMWR Morb Mortal Wkly Rep. 2012;61(22):401–404.
2.
MahanCEBorregoMEWoerschingAL. Venous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost. 2012;108(2):291–302.
3.
VirchowRLK. Phlogose und thrombose im Ge- fa ü ßsystem. Gesammelte Abhandlung zur Wissen- chaftlichen Medizin. Franksfurt, Germany: Staats-druckerei;1856.
4.
DahlbackBCarlssonMSvenssonPJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90(3):1004–1008.
5.
HicksLKBeringHCarsonKR. The ASH Choosing Wisely(R) campaign: five hematologic tests and treatments to question. Hematology Am Soc Hematol Educ Program. 2013;2013:9–14.
6.
LauwMNBarcoSCoutinhoJMMiddeldorpS. Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis. Semin Thromb Hemost. 2013;39(8):913–927.
7.
RabinovichAKahnSR. Association between thrombophilia and the post-thrombotic syndrome. Int J Vasc Med. 2013;2013:643036.
8.
PotdarNGelbayaTAKonjeJC. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2013;19(6):674–684.
